Upcoming Earnings Releases, Quarterly Earnings, Spin-Off, and Market Activity - Research Reports on Mead Johnson, Philip Morris, GoPro, Kimberly-Clark and Kraft Foods

NEW YORK, October 22, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Mead Johnson Nutrition Company (NYSE: MJN), Philip Morris International, Inc. (NYSE: PM), GoPro, Inc. (NASDAQ: GPRO), Kimberly-Clark Corporation (NYSE: KMB) and Kraft Foods Group, Inc. (NASDAQ: KRFT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7365-100free.

--
Mead Johnson Nutrition Company Research Reports
On October 2, 2014, Mead Johnson Nutrition Company (Mead Johnson) reported that it will release it Q3 2014 results and YTD 2014 earnings before opening of the market on October 23, 2014. The release will be followed by a conference call at 8:30 a.m. CDT on the same day during which the Company's executives will discuss quarterly financial performance and take questions from analysts and investors. Analysts polled by Bloomberg Businessweek forecast an EPS (pre-exceptional) of $0.91 on revenue of $1.1 billion for Q3 2014. The full research reports on Mead Johnson are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/MJN/report.pdf

--
Philip Morris International, Inc. Research Reports
On October 16, 2014, Philip Morris International, Inc. (Philip Morris) announced its Q3 2014 results. The net revenues (excluding excise taxes) for the quarter came in at $7.9 billion, down 0.9% YoY, and the diluted EPS was $1.38 compared to $1.44 in Q3 2013. Analysts were expecting earnings of $1.33 per share and $7.6 billion in revenue, according to Thomson Reuters. The total cigarette shipment value for the period was 222.3 billion units, down 0.4% YoY excluding acquisitions. Commenting on the results, André Calantzopoulos, CEO said, "Our results in the third quarter were slightly better than we expected, underpinned by a modest decline in volume, continued robust pricing and solid market share gains in each of our four Regions." The Company now expects its 2014 diluted EPS to be in a range of $4.76 to $4.81. The full research reports on Philip Morris are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/PM/report.pdf

--
GoPro, Inc. Research Reports
On October 13, 2014, GoPro, Inc. (GoPro) announced that it will release its Q3 2014 financial and operating results on October 30, 2014 after closing of the market. Following the results, the Company will host a conference call at 2 p.m. PT (5 p.m. ET) to review its financial performance. A live webcast of the conference call will be accessible on the "Events & Presentations" section of the Company's website. The full research reports on GoPro are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/GPRO/report.pdf

--
Kimberly-Clark Corporation Research Reports
On October 7, 2014, Kimberly-Clark Corporation (Kimberly-Clark) announced the record date, distribution date and distribution ratio details of the previously announced tax-free spin-off of its health care business. The spin-off will result in formation of a new publicly traded company, Halyard Health, Inc. Kimberly-Clark shareholders will get one share of Halyard Health common stock for every eight shares of Kimberly-Clark common stock held as of the close of trading on October 23, 2014. Company's shareholders will receive cash in lieu of any fractional shares. The distribution date for the spin-off is October 31, 2014, when the spin-off is expected to be effective with 100% of the shares of Halyard Health distributed to Kimberly-Clark shareholders. The Company has also increased its 2014 share repurchase target from $1.3-$1.5 billion to $2 billion as it will receive one-time cash payment from Halyard Health before the spin-off completion. The full research reports on Kimberly-Clark are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/KMB/report.pdf

--
Kraft Foods Group, Inc. Research Reports
On October 17, 2014, Kraft Foods Group, Inc.'s (Kraft Foods) shares ended the day's trading session at $54.99, up 1.10% from its previous day's closing price of $54.39. Gains in the stock of Kraft Foods, an American grocery manufacturing and processing conglomerate, tracked the S&P 500 Consumer Staples Index which ended the session 1.14% higher at 460.04. During the session, the stock opened at $54.84 and oscillated within the range of $54.35 and $55.17 with a total of 4.29 million shares changing hands. The stock closed below its 50-day and 200-day moving averages of $56.43 and $55.63, respectively. The full research reports on Kraft Foods are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/KRFT/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED